Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Change in Cash: 2020-2023

Historic Change in Cash for Cullinan Therapeutics (CGEM) over the last 4 years, with Dec 2023 value amounting to $33.6 million.

  • Cullinan Therapeutics' Change in Cash rose 138.83% to $33.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$57.7 million, marking a year-over-year decrease of 159.89%. This contributed to the annual value of -$15.4 million for FY2024, which is 73.27% up from last year.
  • According to the latest figures from Q4 2023, Cullinan Therapeutics' Change in Cash is $33.6 million, which was up 143.63% from -$77.0 million recorded in Q3 2023.
  • In the past 5 years, Cullinan Therapeutics' Change in Cash ranged from a high of $277.4 million in Q2 2022 and a low of -$169.9 million during Q2 2021.
  • Its 3-year average for Change in Cash is -$5.8 million, with a median of -$31.2 million in 2021.
  • Examining YoY changes over the last 5 years, Cullinan Therapeutics' Change in Cash showed a top increase of 801.47% in 2021 and a maximum decrease of 3,069.18% in 2021.
  • Quarterly analysis of 4 years shows Cullinan Therapeutics' Change in Cash stood at $126.9 million in 2020, then tumbled by 122.33% to -$28.3 million in 2021, then tumbled by 205.34% to -$86.5 million in 2022, then skyrocketed by 138.83% to $33.6 million in 2023.
  • Its Change in Cash was $33.6 million in Q4 2023, compared to -$77.0 million in Q3 2023 and $19.7 million in Q2 2023.